Sponsor study identifier
interventional
37
1 country
1
Study Start
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2007
Actual (reported)Study Completion
December 2007
Actual (reported)This study aims: 1\. to assess the effect of smoking reduction programs (behavior therapy alone or behavior therapy with cigarette holders; "Flowers Menthol" plastic cigarettes with menthol) on cigarette smoking habits in an antipsychotic treated schizophrenia population.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
March 13, 2006
Actual (reported)March 14, 2006
Actual (reported)December 2007
Actual (reported)December 2007
Actual (reported)Assessment of smoking dependence:
6 weeks
The Fagerstrom Tolerance Questionnaire for Nicotine Dependence (FTND)
6 weeks
Weekly table for self-report of the number of cigarettes smoked will be filled out by participants with the help of the "smoking supervisors".
6 weeks
Subjective Quality of Life:
6 weeks
Quality of life enjoyment and satisfaction questionnaire -abbreviated version
6 weeks
Clinical Rating Scales:
6 weeks
Positive and Negative Syndrome Scale (PANSS)
6 weeks
Clinical Global Impression (CGI) scale for psychosis
6 weeks
Hamilton Rating Scale for Depression (HAM-D)
6 weeks
Simpson Angus Scale for extrapyramidal side effects (SAS)
6 weeks
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Lev-Hasharon MHC
Netanya, 42100, Israel
Dmitri Rudinski, MD
Lev-Hasharon MHC
Yuval Melamed, MD, MHA
Lev-Hasharon MHC
Olga Preisman, MD
Lev-Hasharon MHC
Deby Peres, MD
Lev-Hasharon.MHC
37 participants (actual enrollment reported by the registry).
First Submitted
March 13, 2006
First Posted
March 14, 2006
Study Start
March 2006
Date type not reportedThis date has not been verified as actual or estimated.
Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia
Contact the study team to confirm eligibility.
Marc Gelkopf, Phd
Lev-Hasharon MHC
Sigalit Noam, RN, BA
Lev-Hasharon MHC
Arturo Lerner, MD
Lev-Hasharon MHC
Avi Bleich, MD, MPH
Lev-Hasharon MHC
Primary Completion
December 2007
Actual (reported)Study Completion
December 2007
Actual (reported)Last Updated
July 22, 2010
Record last verified: 2010-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: